ILSI-HESI cardiovascular safety subcommittee initiative: Evaluation of three non-clinical models of QT prolongation

Batey, 2002, A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs, Journal of Pharmacological and Toxicological Methods, 48, 11, 10.1016/S1056-8719(03)00009-1 Bazett, 1920, An analysis of time relations of electrocardiograms, Heart, 353, 367 Cavalli, 2002, Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K+ channel blockers, Journal of Medicinal Chemistry, 45, 3844, 10.1021/jm0208875 Darpo, 2001, Spectrum of drugs prolonging the QT interval and the incidence of torsades de pointes, European Heart Journal, 3, K70, 10.1016/S1520-765X(01)90009-4 De Cicco, 1999, Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit, Critical Care Medicine, 27, 332, 10.1097/00003246-199902000-00040 De Ponti, 2000, QT-interval prolongation by non-cardiac drugs: Lessons to be learned from recent experience, European Journal of Clinical Pharmacology, 56, 1, 10.1007/s002280050714 Drummer, 1981, Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: Pharmacokinetic measurements following conventional and slow-release propranolol administration, Journal of Pharmaceutical Sciences, 70, 1030, 10.1002/jps.2600700916 Fridericia, 1920, Die Systolendauer im Elektrokardiogramm bei normalen Menchen und bei Herzkranken, Acta Medica Scandinavica, 53, 469, 10.1111/j.0954-6820.1920.tb18266.x Gintant, 2001, The canine Purkinje fiber: An in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis, Journal of Cardiovascular Pharmacology, 37, 607, 10.1097/00005344-200105000-00012 Hamill, 1981, Improved patch clamp techniques for high resolution current recording from cells and cell free membrane patches, Pfluegers Archives, 391, 85, 10.1007/BF00656997 Haysahi, 2005, QT PRODACT: A Multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles, Journal of Pharmacological Sciences, 99, 423, 10.1254/jphs.QT-A1 Hondeghem, 2001, Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic, Circulation, 103, 2004, 10.1161/01.CIR.103.15.2004 Hondeghem, 2003, Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: Importance of triangulation, reverse use dependence, and instability, Journal of Cardiovascular Pharmacology, 41, 1, 10.1097/00005344-200301000-00003 Hondeghem, 1990, Class III antiarrhythmic agents have a lot of potential, but a long way to go: Reduced effectiveness and dangers of reverse rate-dependence, Circulation, 81, 686, 10.1161/01.CIR.81.2.686 Khalifa, 1999, Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine, Journal of Pharmacology and Experimental Therapeutics, 288, 858 Kirsch, 2004, Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern, Journal of Pharmacological and Toxicological Methods, 50, 93, 10.1016/j.vascn.2004.06.003 Koppel, 1987, Clinical symptomatology of diphenhydramine overdose: An evaluation of 136 cases in 1982 to 1985, Journal of Toxicology and Clinical Toxicology, 25, 53, 10.3109/15563658708992613 Little, 1985 Lu, 2005, Choice of cardiac tissue play an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit, Journal of Pharmacological and Toxicological Methods, 50, 90, 10.1016/j.vascn.2005.04.007 Lynch, 1985, Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs, Journal of Pharmacology and Experimental Therapeutics, 234, 72 Miyazaki, 2002, Rate-correction technique for QT interval in long-term telemetry ECG recording in beagle dogs, Experimental Animals, 51, 465, 10.1538/expanim.51.465 Pearlstein, 2003, Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches, Bioorganic and Medicinal Chemistry Letters, 13, 1829, 10.1016/S0960-894X(03)00196-3 Redfern, 2003, Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsades de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development, Cardiovascular Research, 58, 32, 10.1016/S0008-6363(02)00846-5 Sagie, 1992, An improved method for adjusting QT interval for heart rate (the Framingham Heart Study), American Journal of Cardiology, 70, 797, 10.1016/0002-9149(92)90562-D Salata, 1995, Cardiac electrophysiological actions of the histamine H1-receptor antagonist astemizole and terfenadine compared with chlorpheniramine and pyrilamine, Circulation Research, 76, 110, 10.1161/01.RES.76.1.110 Shah, 2002, The significance of QT interval in drug development, British Journal of Clinical Pharmacology, 54, 188, 10.1046/j.1365-2125.2002.01627.x Simons, 1990, Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults and children, Journal of Clinical Pharmacology, 30, 665, 10.1002/j.1552-4604.1990.tb01871.x Spence, 1998, The heart rate-corrected QT interval of conscious beagle dogs: A formula based on analysis of covariance, Toxicological Sciences, 45, 247, 10.1093/toxsci/45.2.247 Sugiyama, 2002, Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs, Japanese Journal of Pharmacology, 88, 341, 10.1254/jjp.88.341 Sugiyama, 2001, In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol, Toxicology and Applied Pharmacology, 173, 120, 10.1006/taap.2001.9168 Toyoshima, 2005, QT PRODACT: In vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals, Journal of Pharmacological Sciences, 99, 459, 10.1254/jphs.QT-A2 Tristani-Firouzi, 2001, Molecular biology of K+ channels and their role in cardiac arrhythmias, American Journal of Medicine, 110, 50, 10.1016/S0002-9343(00)00623-9 Valentin, 2004, Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs, Journal of Pharmacological and Toxicological Methods, 49, 171, 10.1016/j.vascn.2004.03.008 Webster, 2001, Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog, Xenobiotica, 31, 633, 10.1080/00498250110054632 Zeraba, 1997, Electrocardiographic findings in patients with diphenhydramine overdose, American Journal of Cardiology, 80, 1168, 10.1016/S0002-9149(97)00634-6 Zhang, 1999, Mechanism of block and identification of the verapamil binding domain to HERG potassium channels, Circulation Research, 84, 989, 10.1161/01.RES.84.9.989